SLC1A2 and Parkinson disease: Non-cell-autonomous mechanisms also contribute to excitotoxicity in these prominent neurodegenerative disorders, as decreased expression of the astrocytic glutamate transporter EAAT2 (also known as SLC1A2) has been reported in AD, HD, and PD [18,19,20].